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The functional r61e of bacterial polysaccharides in immunity has been 
amply demonstrated in studies from this and other laboratories.  Although 
knowledge of  the precise chemical constitution of  the bacterial polysac- 
charides is still meager, it has been possible in some measure to correlate 
their specific immunological properties with differences in chemical struc- 
ture.  Several years ago we demonstrated  that type specific antibacterial 
immunity could be evoked in rabbits with an artificial antigen  containing 
the azobenzyl ether of  the capsular polysaccharide of Type III Pneumoco- 
coccus (1).  More recently it has been shown that an antigen containing the 
azobenzyl glycoside of cellobiuronic acid, the pattern unit of the Type III 
pneumococcus polysaccharide, evokes in rabbits  antibodies  which agglu- 
tinate Type III pneumococci and confers passive immunity on mice against 
infection not only with Type III but with Type II and VIII organisms as 
well (2). 
Cellobiuronic  acid  (4-/~-glucuronosidoglucose)  is  an  aldobionic  acid 
constituted  from  a  molecule of glucose linked in  /~-glucuronosidic  union 
with a molecule of glucuronic acid on the fourth carbon atom of the hexose 
(3).  Whether this exact molecular configuration is essential for eliciting 
pneumococcal antibodies  in  experimental  animals  is  the  subject  of  the 
present  communication.  A  second antigen has  therefore been prepared, 
one  containing  an  isomeric  aldobionic  acid,  gentiobiuronic  acid  (6-/5- 
glucuronosidoglucose) (4).  The immunological properties  of the antigen 
containing the  synthetic  saccharide have  been  compared  and correlated 
with those of the antigen containing cellobiuronic acid, the aldobionic acid 
derived from natural sources.  Cellobiuronic and gentiobiuronic acids are 
isomers differing in  the position  but  not  the  configuration of  the B-glu- 
curonosidic union as can be seen from Figs.  1 and 2. 
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Any differences in the immunological properties of the antigens contain- 
ing the two aldobionic acids can be directly correlated with differences in 
their  chemical  constitution since  the  latter  is  known.  For  purposes of 
comparison there have been included in this investigation a  study of the 
immunological  properties of antigens containing the azobenzyl glycosides of 
glucuronic and galacturonic acids and the disaccharide gentiobiose.  The 
structural relationship  of these  saccharides has been  discussed in earlier 
H  OH  CH~OH 
o  I/o~  ~\1  ,~! 
COOH  H  OH 
CeUobiuronic acid 
(4-#-glucuronosidoglucose) 
FIG. 1 
H  OH 
HO/~  \  H 
!\i  o/ 
COOH 
CH2 
•  i2 ! 
H  OH 
Gentiobiuronic acid 
(6-/~-glucuronosidoglucose) 
FIG. 2 
communications.  That the chemical structure of these derivatives is the 
sole factor determining the immunological properties of antigens in which 
the saccharides are incorporated will be seen from the following account. 
EXPERI~FENTAL 
Chemical 
tteptaacetytgentiobiuronic  Acid  Methyl  Ester.--This  derivative  was  prepared  by 
condensing 1,2,3,4 tetracetyl glucose (5)  with  acetobromoglucuronic  acid  methyl WALTHER  F.  GOEBEL  35 
ester (6).  By employing the method recommended by Reynolds and Evans (7) for the 
general synthesis of glycosides, yields of 60 per cent of the acetylated aldobionic acid 
methyl ester were obtained. 
Acetobromogentiobiuronic  Acid Methyl Ester.--14.3  gm. of heptaacetylgentiobiuronic 
acid methyl ester were dissolved in 60 co. of dry chloroform.  60 co. of glacial acetic 
acid  saturated  with  hydrobromic  acid  were  added.  After  30  minutes  the  mixture 
was poured into  800  co.  of ice and  water.  The mixture was  extracted with  250  ce. 
of alcohol-free chloroform and  washed  three  times with  ice water.  After drying the 
chloroform solution with  sodium sulfate,  the  solvent was  evaporated in  vacuo.  The 
oily residue was dissolved in anhydrous ether whereupon crystals of acetobromogentio- 
biuronic acid methyl  ester separated.  4.0  gin.  were  recovered.  The  derivative was 
recrystallized several times by dissolving in  warm chloroform (40 cc.)  and adding an 
equal  volume  of  ether.  The  compound  crystallized as  rosettes  of  needles  melting 
with decomposition at  192 °  (uncorrected). 
Rotation.--[a]~*  --  -t-99.2 ° in CHCI3 (C  =  0.8 per cent). 
Analysis.--C2sH~OzTBr.  Calculated.  Br 11.7. 
Found.  Br 11.9. 
p-Nitrobenzylglycoside  of Hexaacetylgentiobiuronic  Acid Methyl Ester.--1.5  gin.  of 
p-nitrobenzyl alcohol were  dissolved in  10  co.  of  dry  chloroform.  1.5  gm.  of  silver 
oxide were added and  10 gin. of Drierite previously heated for 2  hours at 240  °.  The 
mixture was stirred 1 hour in an apparatus bearing a  mercury sealed stirrer.  0.32 gin. 
of iodine were then added and a solution of 4.3  gin.  of acetobromogentiobiuronie acid 
methyl ester dissolved in 35 co. of dry alcohol-free chloroform was added from a dropping 
funnel over a  period of 1 hour.  After stirring overnight, the mixture was filtered and 
the  chloroform evaporated from  the  filtrate in  vacuo.  The  resulting syrup  was  dis- 
solved in ethyl alcohol, whereupon the glycoside crystallized  from the solution.  4.3 gin. 
of pure glycoside were recovered; the derivative crystallizes as needles melting at 113- 
115  °  (uncorrected). 
Rotation.--[c~]~*  =  -42.2  ° in CHCI3 (C  -  1.1 per cent). 
Analysis.--C3oHsGOlsN  (COOCHs). 
Calculated.  C 50.7, H  5.2,  CHsO 4.1, N  1.85. 
Found.  C 50.7, H  5.3, CH30 3.8, N  1.80. 
O p-Nitrobenzylglycoside  of Gentiobiuronic  Acid Methyl Ester.--3.15 gin. of the acetyl- 
ated glycoside were suspended in  100 co. of cold anhydrous methyl alcohol and  i  co. 
of N/1  barium methylate  (8)  was  added.  The mixture was  shaken  1  hour  at  room 
temperature and then allowed to stand for 2 hours more.  1 cc. of N/1 H2SO4 was added, 
the  precipitated barium  sulfate  removed  by  centrifugation,  and  the  solution  of  the 
deaeetylated glycoside evaporated in vacuo  to  10 co.  On  standing at 0 °  the solution 
deposited crystals of  the  p-nitrobenzylglycoside of  gentiobiuronic acid methyl  ester. 
2.0 gin.  were recovered.  The glycoside was  recrystallized several times from methyl 
alcohol.  The  substance  was  obtained  as  fine  silky  needles  melting  at  107-110  ° 
(uncorrected). 
Rotation.--[a]~ ° --  -58.3  ° in CHsOH (C  -- 0.9 per cent). 
Analysis.--C~oH2701,N.  Calculated.  OCH3 6.2, N  2.8. 
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Barium  Salt  of  p-Amlnobemylglycoside  of  Gentiobiuronic  Add.--2.2  gm.  of  the  0 
p-nitrobenzylglycoside of gentiobiuronic acid methyl ester were dissolved in 100 co. of 
methyl  alcohol  and  reduced  catalytically with  hydrogen  using  50  mg.  of  platinum 
oxide  as  catalyst  (9).  The  derivative  utilized  exactly  the  theoretical  quantity  of 
hydrogen.  The solution was then filtered and the solvent evaporated in vacuo.  The 
aminobenzylglycoside of gentiobiuronic acid methyl ester was now dissolved in  50  co. 
of ethyl alcohol and one equivalent of 0.4 N barium hydroxide was slowly added from 
a  burette.  The solution was treated with Norite, filtered, and concentrated to a  pale 
yellow oil.  The latter was slowly poured into a  liter of chilled acetone.  The barium 
salt of the gentiobiuronide separated as a  faintly yellow amorphous precipitate.  The 
salt was collected by filtration; 2.18 gm. were recovered. 
Rotation.--[c,]~ °  =  -57.1 ° in H~O (C  =  0.5 per cent). 
Analysis.--C19H~6012N½Ba.  Calculated.  N  2.7, Ba 13.0. 
Found.  N  2.4, Ba 12.4. 
HeptaacetyI  O  p-Nitrobemylgentiobioside.--This  derivative  was  prepared  by  con- 
densing 1.67  gm.  of acetobromogentiobiose (10)  with 5.8 gm.  of p-nitrobenzyl alcohol 
and  5.7  gin.  of  silver oxide according to  the  technique  of  Reynolds and  Evans  (7). 
The glycoside was obtained from the reaction mixture as described for the corresponding 
glycoside of gentiobiuronic acid methyl ester.  6.6 gm. of pure glycoside were recovered 
by repeated recrystallization of  the  reaction product from  methyl alcohol.  The  de- 
rivative was obtained as glistening needles melting at 171-172 ° (uncorrected). 
Rotation.--[a]~ ° =  -38.5  ° in CHCI~ (C  -~ 0.7 per cent). 
Analysis.--C~3H410~oN.  Calculated.  C  51.4, H  5.4. 
Found.  C 51.3, H  5.4. 
O p-Nitrobenzylgentiobioside.--5.0 gin. of the heptaacetyl 0 p-nitrobenzylgentiobioside 
were suspended in  100  co. of methyl alcohol and deacetylated with barium methylate 
exactly as was the corresponding glycoside of gentiobiuronic acid; 2.8 gin. of glycoside 
were  recovered  from  the  mother  liquors.  The  derivative  crystallizes in  rosettes  of 
needles melting at 120  °  (uncorrected) preceded by softening at 113  ° . 
Rotation.--[a]~  ~°  --  -46.8  ° in H~O  (C  =  1.2 per cent). 
Analysis.--CjgH~O13N.  Calculated.  C 47.8, H  5.6, N  2.9. 
Found.  C 47.9, H  5.7, N  2.6. 
p-Aminobemylgentiobioside.--The  0 p-nitrobenzylgentiobioside was  reduced  cata- 
lyrically according to the directions outlined for the  preparation of the corresponding 
glycoside of gentiobiuronic acid methyl ester.  In carrying out the reduction the theo- 
retical quantity of hydrogen was utilized.  It was not possible to obtain the glycoside 
in  a  crystalline state.  The  aminobenzylglycoside has  been  secured only  as a  syrup, 
having the correct analysis. 
Rotation.--[a],  =  -49.7  ° in H20 (C  =  1 per cent). 
Analysis.--C19H~90nN.  Calculated.  N  3.13. 
Found.  N  3.08. 
O  p-Aminobenzylglycosides  of  Cellobiuronic,  Glucuronic,  and  Galacturonic  Acids.- 
These derivatives were prepared by methods previously described (2, 11). WALTHER  F.  GOEBEL  37 
Immunological 
Methods.--The immunizing and test antigens containing the azo derivatives of the 
p-aminobenzylglycosides of cellobiuronic,  gentiobiuronic,  glucuronic,  and galacturonic 
acids and of gentiobiose were prepared by methods previously outlined.  The method 
of intravenous injection of rabbits as well as the technique of passive immunity tests 
in mice were the same as those used in former studies.  Precipitin reactions and specific 
inhibition  tests were conducted  in  the  usual  manner.  For  the  sake of brevity, im- 
munizing antigens will be referred to in the tables as CA-globulin  (cellobiuronic  acid- 
globulin),  GeA-globulin  (gentiobiuronic acid-globulin),  and GaA-globulin  (galacturonic 
acid-globulin).  Test  antigens  prepared  by  combining  the  various  glycosides  with 
chicken serum are referred to as CA-chick, etc.  The p-aminobenzylglycosides used as 
TABLE  I 
Homologous and Heterologous Precipitin Reactions of Cellobiuronic Acid, Gentiobiuronic 
Acid, and Gentiobiose Antisera 
Antiserum prepared by 
immunization with 
CA-globulin 
GeA-globulin 
Ge-globulin 
Test antigen used 
CA--chick 
GeA  " 
Ge  " 
CA  t~ 
GeA  " 
Ge  " 
CA  t, 
GeA  " 
Ge  ~c 
Final dilution of test antigen 
I:I0,000  1:25,000 
+++  ++ 
++  ++ 
0  0 
+±  ++ 
+++  +++ 
++±  ++± 
0  0 
+±  +± 
+++  +++ 
1:50,000 
++ 
+± 
0 
o 
+++ 
++q- 
o 
+± 
+++ 
inhibiting agents are referred to as CA, GeA, G1A, GaA, and Ge for the cellobiuronide, 
gentiobiuronide, glucuronide,  galacturonide,  and gentiobioside respectively. 
Precipitin Reactions 
Antisera  of Rabbits  Immunized  with Antigens  Containing  the  Azobenzyl 
Glycosides.--The  two  isomeric  aldobionic  acids  cellobiuronic  and  gentio- 
biuronic  acids  are  constituted  from  molecules  of  glucose  and  glucuronic 
acid linked in ~-glucuronosidic union  on the fourth and  sixth  carbon atom 
of  the  hexose  respectively.  The  disaccharide  gentiobiose  differs  from the 
corresponding aldobionic acid  only in the nature of the grouping occupying 
the twelfth position.  In the disaccharide this grouping is a  primary alcohol 
(CH~0H) and in the uronic acid a  carboxyl group.  The sera of rabbits im- 
munized  with  antigens  containing  these  three  saccharides  show  marked 
precipitation  with  the  homologous  test antigens  as  seen  in  Table  I.  The 38  IMMUNITY  INDUCED  BY  ARTIFICIAL  ANTIGENS.  II 
ceUobiuronic acid antiserum cross reacts with the  test  antigen containing 
the isomeric aldobionic acid, but  not with that containing the disaccharide 
TABLE  II 
Inhibition of Precipitins in CeUobiuronic Acid Antiserum by Homologous and 
Heterologous Glycosides 
Inhibiting glycoside 
Cellobiuronlc acid antiserum 
Test antigen 1:10,000 
CA--chick  GeA---chick 
CA ................................  0  0 
GeA ...............................  +++  0 
C-e ................................  +++  +++ 
None ..............................  ++++  +++ 
TABLE  III 
Inhibition of Precipitins in Genliobiose Antiserum  by Homologous and 
Heterologous Glycosides 
Gentiobiose antiserum 
Inhibiting glycoside  Test antigen 1:10, 000 
Ge--chick  GeA--chick 
Ge ................................  0  0 
GeA ...............................  +++  0 
CA ................................  +++  ++ 
None ..............................  +++4-  ++ 
TABLE  IV 
Inhibition of Precipitins in Gentiobiuronic Acid Antiserum by Homologous and 
Heterologous Glycosides 
Gentiobiuronic  acid antiserum 
Inhibiting glycoside 
GeA  ........................ 
Ge  .......................... 
CA  ......................... 
None ........................ 
GeA--chick 
o 
+++ 
+++ 
+++ 
Test antigen 1:10,000 
Ge---chick 
o 
o 
++ 
+++ 
CA--chick 
o 
+++ 
o 
++± 
gentiobiose.  Likewise the  gentiobiuronic acid serum cross reacts with the 
cellobiuronic acid  antigen.  This cross  reaction can be attributed only to WALTHER  F.  GOEBEL  39 
the common glucuronic acid constituent.  Gentiobiuronic  acid antiserum 
on the other hand cross reacts with the gentiobiose test antigen and vice 
versa.  These cross reactions can in all probability be directly attributed to 
the close constitutional similarities of the two saccharides in question.  It 
is of interest to observe that the antiserum evoked by the antigen containing 
the  disaccharide  genfiobiose  does not  cross  react  with  the  cellobiuronic 
acid test antigen.  Although these two saccharides have a glucose molecule 
in common, it is apparent that this common constituent is not reflected in 
the  immune sera  either  to  the  cellobiuronic acid or gentiobiose  antigen. 
That the antibodies evoked by each antigen are indeed specific and that 
the cross reactions are quite secondary is evident from the results of the 
TABLE  V 
Precipitin Reaction of Gentiobiose and Gentiobiuronic Acid Antigens in 
Antipneumococcal Horse Sera 
Antipneumo- 
coccus  horse 
seruln 
II 
III 
V 
VIII 
Test antigen used 
Gc  chick 
GeA  " 
Ge  " 
GeA  " 
Ge  ¢~ 
GeA  " 
GeA  " 
Final dilution of test antigen 
1:10,000  1:50,000  1:250,000  1:1,000,000 
+4- 
++ 
+ 
+++ 
+ 
++++ 
++4- 
+++ 
-4- 
+4- 
4- 
++ 
0 
+++ 
+4- 
+± 
0 
+ 
0 
+± 
0 
++ 
-4- 
+ 
0 
0 
+ 
0 
+ 
0 
4- 
specific inhibition  tests given in Tables  II,  III,  and IV.  Here it can be 
seen that in all instances the homologous reaction is inhibited only by the 
homologous glycoside and in no instance by heterologous glycosides.  The 
cross reactions, as might be expected, are inhibited in all cases by the ho- 
mologous glycoside and  by  the  glycoside common  to  each  test  antigen. 
Precipitin Reactions of Antitmeumococcal Sera with Test Antigens Contain- 
ing the Glycosides.--In previous studies we have shown that artificial anti- 
gens containing cellobiuronic and glucuronic acids react in antipneumococcal 
horse sera Types II,  III,  and VIII in  dilutions as high as one part in  a 
million of  the  test  antigen.  It  has  now been found that  gentiobiuronic 
acid  test  antigen  likewise  reacts  in  these  antisera  and  in  Type V  anti- 
pneumococcal horse serum as  well (Table V).  The precipitation of these 40  IMMUNITY INDUCED BY  ARTIFICIAL ANTIGENS.  11 
uronic acid antigens in antipneumococcal horse sera has  been attributed to 
the reaction of the antigen with uronic acid antibodies evoked in the horse 
by the type specific bacterial  antigen which likewise contains uronic acids. 
The precipitation  of the gentiobiuronic  acid antigen  in Type V  antiserum 
would be difficult to  understand  on  the basis of the work of Brown  (12) 
who reports that  the Type V  polysaccharide contains no uronic acid.  In 
this laboratory,  however, we have  recently isolated  the  Type V  polysac- 
charide  and have found that after acid hydrolysis it gives a  distinct color 
TABLE VI 
Inhibition  of Precipitin Reactions of Cellobiuronic and Gentiobiuronic Acid Antigens in 
Antipneumococcus Horse Sera 
Antipneumococcus 
horse serum 
Type 
II 
III 
V 
VIII 
Inhibiting glycoside  ~/10 
CA 
GeA 
G1A 
None 
Ca 
GeA 
G1A 
None 
CA 
GeA 
G1A 
None 
CA 
GeA 
G1A 
None 
Test antigens (1:10,000) 
CA--chick  GeA--chick 
0 
0 
0 
+++ 
0 
++++ 
++++ 
++++ 
0 
0 
0 
+++ 
0 
++++ 
++++ 
++++ 
0 
0 
0 
+++ 
0 
0 
0 
+++ 
o 
0 
0 
+++ 
0 
o 
0 
+++ 
test for uronic acids with naphthoresorcinol.  That the precipitation of gen- 
tiobiuronic acid test antigen  in the antipneumococcal sera is a  function of 
the uronic acid constituent is apparent from the results presented in Table 
V,  for here  it  is  seen  that  the  corresponding  antigen  containing  the  di- 
saccharide gentiobiose shows little or no predpitation in these types of anti- 
pneumococcal sera,  save that  of Type VIII.  The  reason  for the precipi- 
tability of the disaccharide antigen in this type of antipneumococcal serum 
cannot be given until a more comprehensive understanding  of the chemical 
makeup of the Type VIII polysaccharide is had. WALTHER  ~F.  GOEB:EL  41 
The results of the inhibition of  the precipitin reactions of gentiobiuronic 
and cellobiuronic acid antigens in antipneumococcal horse sera of various 
types is given in Table VI.  It will be observed that the precipitation of 
both aldobionic acid antigens in Type II and V antipneumococcal sera  is 
in all  instances inhibited indiscriminately by the p-aminobenzylglycosides 
of  glucuronic,  gentiobiuronic,  or  cellobiuronic acids.  Furthermore,  the 
precipitation of the gentiobiuronic acid antigen in Type III and VIII anti- 
sera  is  also  inhibited by  all  of  the  glycosides, but  the reaction of  cello- 
biuronic acid antigen in these same sera is inhibited only by the homologous 
glycoside. 
Now it  has  been  demonstrated (13) that cellobiuronic acid is a constit- 
uent  of  the  Type  III  and  VIII  pneumococcus  polysaccharides.  The 
results of  these  specific inhibition tests indicate, therefore, that  the pre- 
cipitation of the cellobiuronic acid antigen in these two types of antipneu- 
mococcal sera is of a  more specific nature than is the precipitation of the 
gentiobiuronic acid antigen.  In a  sense, the reaction of the cellobiuronic 
acid antigen in Type III and VIII antisera may be regarded as type specific. 
The precipitation of  the gentiobiuronic acid  antigen appears  to  be  non- 
specific.  The reaction occurs only by virtue of the glucuronic acid constit- 
uent,  since it  is  inhibited  by  any  glycoside containing glucuronic acid. 
The precipitation of the two aldobionic acid antigens in Type II and V 
antisera may likewise be considered as non-specific for here again both re- 
actions are inhibited indiscriminately by all the uronides.  From the results 
of these tests it might indeed be inferred that neither cellobiuronic nor gen- 
tiobiuronic acids are constituents of the Type II and V pneumococcus poly- 
saccharides.  This inference must await further experimental proof before 
it is possible to say that the aldobionic acid constituents of bacterial poly- 
saccharides can be determined by serological as well as chemical technique. 
Neufeld Quellung Reactions.--In the previous communication (2)  it was 
shown that the sera of rabbits immunized to the artificial antigen containing 
cellobiuronic acid showed a typical swelling of the capsule of young actively 
growing Type III pneumococci when the organisms and serum were mixed. 
In the present study we have observed that the sera of rabbits immunized 
to the isomeric gentiobiuronic acid cause no detectable swelling of the cap- 
sule of Type II or III pneumococci.  This point will be discussed further 
in the section dealing with the protective action of these antisera. 
Agglutinins.--The sera of rabbits injected with the two aldobionic acid 
antigens were tested for agglutinins with heat-killed suspensions of Type 
II  and  III pneumococci.  The results of  these experiments are given in 
Table VII.  Here it can be seen that the sera of rabbits immunized to the 42  IMMUNITY  INDUCED  BY  ARTIFICIAL  ANTIOENS.  II 
ceUobiuronic acid antigen agglutinate Type III pneumococci (as previously 
found), but not Type II organisms whereas the gentiobiuronic acid anti- 
serum fails to show any demonstrable agglutinating activity with pneumo- 
cocci of either type. 
TABLE  VII 
Agglutination  of  Type  II  and  III  Pneumococci  in  CeUobiuronic and  Gentiobiuronic 
Acid Antisera 
Antiserum  prepared by 
immunization  with 
CeUobiuronic acid globulin 
Genfiobiuronic acid glob- 
ulin 
Pneumococcus 
Types 
II 
III 
II 
III 
Final dilution of serum 
1:10  1:20  1:~  1:80  1:160 
+o+  d+  d+  +o+  o  + 
0  0  0  0  0 
0  0  0  0  0 
TABLE  VIII 
Protective Action  of  Gentiobiuronic  Acid  Antiserum  against  Pneumococcal Infection 
in Mice 
Pneumococcus 
Amount  of culture 
GC° 
lO-  s 
10-4 
Virulence controls (no 
serum) 
lO  ~ 
lO-7 
lo-8 
Type II  Type III  Type V  Type VIII 
S  D 108 
S  S 
S  S 
S  S 
D 48 
D  48 
D  48 
B 
D40  D40 
D40  D42 
D  40 
D40 
D48 
m 
D40  D40 
D40  D40 
D 28 
D40 
D 48 
D24  D24 
D24  D36 
D  24 
D  24 
D 48 
In this and the following tables S indicates survived; D  indicates death, the numerals 
representing the hours before death of the animal occurred. 
Protective Antibodies.  A.  Gentiobiuronlc Acid Antiserum.--It  has been 
previously shown (2) that the serum of rabbits immunized to the artificial 
antigen  containing  cellobiuronic acid  confers  passive  immunity on  mice 
against infection with Type II, III, and VIII pneumococci.  In the present 
study  protection  tests  have  been  done in  mice infected with Type  II, 
III, V, and VIII pneumococci using gentiobiuronic acid antiserum.  The 
results of these tests are given in Table VIII. WALTHER  F.  GOEBEL  43 
From the results given in Table VIII it is apparent that the sera of rabbits 
injected with the gentiobiuronic acid antigen, unlike those immunized with 
the cellobiuronic acid antigen (2) fail to protect mice against infection with 
Type  III,  V,  or  VIII  pneumococci.  However,  the  gentiobiuronic acid 
antiserum does confer passive immunity on mice against infection with as 
much as 100,000 minimal lethal doses of Type II organisms, although the 
antiserum apparently neither agglutinates nor causes swelling of the capsule 
of this particular type of organism.  It is possible to demonstrate that the 
protective  antibodies  are  specifically absorbed  by  encapsulated Type  II 
pneumococci but not by the unencapsulated R  variant derived therefrom 
(Table  IX). 
TABLE  IX 
Protective Action of Gentiobiuronic Acid Antiserum before and after Absorption with Type 
II S and R Pneumococci 
Pneumococcus Type II 
CG. 
10-  4 
10-  5 
Virulence controls (no 
serum) 
i0--7 
10-8 
Unabsorbed 
S  S 
S  S 
S  S 
Oentiobinronic  acid antiserum 
Absorbed with Type II 
S pneumococcl 
D24  D24 
D24  D24 
D 48  D 48 
Absorbed with R organisms 
derived from Type ti 
PnetliXlococcus 
S  D108 
SS 
SS 
D48 
D  24 
D48 
D 48 
D 48 
D 48 
According to the older classification of pneumococci, the present Type V 
was considered a subgroup of Type II, for it was known that Type II anti- 
serum protected mice against infection with atypical II a  (Type V) organ- 
isms.  Although the gentiobiuronic acid antigen precipitates in high dilu- 
tion in Type V antipneumococcal horse serum (Table V) the antiserum to 
the uronic acid fails to protect mice against infection with Type V organ- 
isms.  The reason for this is at present not clear. 
B.  Gentiobiose Antiserum.--In  the  previous  study  of  this  series  (2)  it 
was demonstrated that an antiserum evoked by an antigen containing the 
disaccharide cellobiose  failed to protect mice against  infection with Type 
II,  III,  and  VIII pneumococci although the  corresponding cellobiuronic 
acid  antiserum  did.  Similarly  we  have  now found  that  the  antibodies 
evoked by  an  antigen  containing the  azobenzyl glycoside of gentiobiose 44  IMMUNITY  INDUCED  BY  ARTIFICIAL  ANTIGENS.  II 
(Table X) fail to protect mice against infection with Type II pneumococci. 
This fact emphasizes once again the importance of the uronic acid structure 
in determining the nature of the immunological response in the host. 
C. Glucuronic and Galacturonic Acids.--The fact that antisera evoked by 
antigens  containing  the  isomeric  cellobiuronic  and  gentiobiuronic  acids 
both confer immunity on mice against infection with Type II pneumococci 
and at  the same time show highly specific  differences in protecting mice 
against  Type  III  pneumococcal infection  seems  paradoxical.  However, 
cellobiuronic  and  gentiobiuronic  acids  contain  a  common  constituent, 
namely glucuronic acid, which might be capable of evoking Type II anti- 
bacterial  immune  bodies  in  rabbits.  Consequently  the  sera  of  rabbits 
immunized to antigens containing the simple hexose uronic acids glucuronic 
and galacturonic acids were tested for their ability to protect mice against 
TABLE  X 
Protective Action of Gentiobiose Antiserum against Type II Pneumococcal Infection in Mice 
Pneumococcus Type II  Gentiobiose antiserum 
lOs 
10-~ 
Virulence controls (no serum) 
10  ~ 
lO-r 
lO s 
D24  D48 
D72  D72 
D72  D48 
D  48 
D  24 
S 
infection with Type II pneumococci and at the same time an immune serum 
to  an  antigen containing the hexose glucose was also  tested.  It will be 
recalled that  the antisera evoked in  rabbits  by  antigens  containing glu- 
curonic and galacturonic acids show no serological crossings  (11).  It will 
be  recalled,  furthermore,  that  glucuronic  and  galacturonic acids  differ 
only in  the  configuration of the fourth asymmetric carbon atom,  yet this 
structural difference endows each antigen with a clearly defined serological 
specificity.  Glucuronic  and  galacturonic  acid  antisera  exhibit  sharply 
defined specificities  not only in their serological  characteristics but in their 
ability to  confer passive immunity on mice to Type II pneumococcal in- 
fection.  The antisera to galacturonic acid is quite ineffectual in conferring 
passive immunity against Type II pneumococcal infection.  The antiserum 
to the antigen containing the synthetic glucuronide on the other hand pro- WALTHER  F.  GOEBEL  45 
tects mice against  infection with  100,000 minimal lethal doses of Type II 
pneumococci, but  not  against  Type III organisms  (Tables XI  and  XII). 
An antiserum elicited by an antigen containing glucose, on the other hand, 
TABLE XI 
Protective Action  of Glucose, Glucuronic Acid,  and  Galacturonic Acid Antisera  against 
Type II Pneumococcal Infection in Mice 
Antiserum tested 
Pneumococcus Type II 
Glucose-globulin  Glucuronic  acid-globulin  Galacturonic  acid-globulin 
10-* 
10  ~ 
l0 s 
10-e 
10--7 
Virulence controls (no 
seruln) 
10  ~ 
10--7 
l0 s 
D24  D24  D24 
D24  D44  D44 
D44  D66  S 
D18  D44 
D24  D24 
D24  D24 
D72  D66  S 
S  S  S 
S  S  S 
S  S  S 
D24  D24 
D48  D48 
D48  D48 
--  m 
D24  D24 
D24  D24 
D24  D24 
D 24 
D 24 
D48 
TABLE  X_II 
Protective Action of Glucuronic Acid A ntiserura before and  after A bsorptlon witk Type II 
S and R Pneuraococci 
Glucuronic acid antiserum 
Pneumococcus Type II 
CC. 
10-a 
10-5 
I0  ~ 
Virulence controls (no 
serum) 
10-6 
10-7 
10-s 
Unabsorbed 
S  S 
S  S 
S  S 
Absorbed with Type II 
S pneumococct 
D 24  D 24 
D24  D24 
D24  D24 
D24  D48 
D24  D24 
D24  D48 
Absorbed with R organisms 
derived from Type II 
Pneumococcus 
S  D48 
S  S 
S  S 
contains  no  protective  antibodies  against  Type  II  infection.  By  means 
of absorption tests  (Table XII)  it has also been possible  to show that the 
protective antibodies in glucuronic acid antiserum are specifically absorbed 46  IMMUNITY  INDUCED  BY  ARTIFICIAL  ANTIGENS.  II 
by encapsulated Type II pneumococci but not by the corresponding un- 
encapsulated  R  strain.  From  the  results  of  these  experiments it  seems 
justifiable to  conclude that the protective action of cellobiuronic, gentio- 
biuronic, and glucuronic acid antisera against Type II pneumococcal in- 
fection in mice is in each instance attributable to antibodies evoked by the 
glucuronic acid constituent. 
DISCUSSION 
In view of increasing evidence accumulated during the past  few years 
there remains little doubt that the specificity of the various pneumococcal 
types may be directly attributed to differences in chemical nature of their 
capsular polysaccharides.  Our knowledge of the precise chemical structure 
of  the  specific  carbohydrates of  this  important  group  has  unfortunately 
remained obscure ever since the  time of  their  discovery some seventeen 
years ago.  The technical and economic difficulties encountered in procuring 
sufficient material  for  investigation by  the  classical  methods  of  organic 
chemistry have in themselves been a factor in deterring the pursuit of this 
problem.  Most of the efforts in this and other laboratories have been con- 
fined to an investigation of the physical properties of the polysaccharides, 
to the identification of the sugars from which they are constituted, and to a 
study of their immunological characteristics.  The fact remains, however, 
that an understanding of the specificities  of the various types of pneumo- 
cocci will be had only after the structures of their capsular polysaccharides 
have been fully elucidated.  The problem has become one strictly chemical 
in nature and its magnitude is emphasized by the recent contribution of 
Brown  (12) who has  now isolated and in part  characterized the specific 
substances from all of the known pneumococcai types hitherto unstudied. 
The study of the factors underlying the specificity of immunologically 
active polysaccharides has been greatly facilitated by the use of the method 
so brilliantly conceived and developed by Landsteiner and his collaborators 
in their immunological investigations of azopr0tein antigens (14).  Many 
of our efforts have been devoted to an investigation of the immunological 
properties  of  artificially  conjoined  carbohydrate-proteins  containing 
saccharides of known structure.  The fertility of this field remained some- 
what limited until it was discovered that artificial antigens containing sim- 
ple hexose uronic acids acquired some of the serological characteristics of 
the  pneumococcal polysaccharides  themselves.  Knowledge of  the  close 
relationship of these artificial antigens to the bacterial polysaccharides has 
now  stimulated  efforts  to  investigate  further  the  specific  immunological 
properties of uronic acids and has led to experiments in which attempts have 
been made to incite in experimental animals antibacterial immunity with WALTItER  ~.  (~0~BEL  47 
artificially  compounded substances.  Earlier  efforts  to  evoke  in  rabbits 
immunity to Type I, III, and VIII pneumococci with antigens containing 
glucuronic and galacturonic acids were unsuccessful.  Recently however it 
was found  that  when an  antigen is  employed  containing the  azobenzyl 
glycoside of cellobiuronic acid, the artificially prepared complex gives rise 
in rabbits to antibodies which confer passive immunity on mice to infection 
with Type II, III, and VIII pneumococci. 
The uronic acid constituent of the Type II carbohydrate is still unknown 
and it is therefore not easy to explain the protective action of cellobiuronic 
acid antiserum on mice infected with  this type of microorganism.  Cello- 
biuronic acid  has  however been identified as  a  constituent of  the Type 
III and VIII polysaccharides and  the immunological properties exhibited 
by  the  corresponding  uronic  acid  antiserum  are  therefore  quite  under- 
standable.  Whether  the  exact  molecular  structure  possessed  by  cello- 
biuronic acid is the essential factor which endows this substance with these 
important  immunological properties  has been  the  subject of  the present 
investigation. 
From the results of experiments in which an antigen containing an isomer 
of cellobiuronic acid namely gentiobiuronic acid has been used it is evident 
that an alteration in position without change in configuration of the glu- 
curonosidic linkage endows the new antigen with distinctly different im- 
munological  properties.  The  antigen  containing  the  synthetic  gentio- 
biuronic acid is incapable of inciting in rabbits antibodies which agglutinate 
Type III pneumococci or confer passive immunity on mice against infection 
with either Type III or VIII organisms.  It is apparent, therefore, that the 
particular structure of cellobiuronic acid determines not only the immuno- 
logical specificity of the aldobionic acid but in part that of the parent poly- 
saccharide of which it forms a  structural unit.  The same principle is ap- 
plicable in explaining the protective action of cellobiuronic acid antiserum 
against Type VIII pneumococcal infections although in this instance the 
complete pattern unit is not as yet fully known. 
Without knowledge of the uronic acid constituent of the Type II pneumo- 
coccus polysaccharide it is difficult to understand the protective action of 
both cellobiuronic and gentiobiuronic acid antisera against infection with 
this type of microorganism.  The explanation becomes dearer however since 
it  is  now known that  glucuronic acid  antiserum  also  has  this  property. 
The protective antibodies in all three antisera are obviously those directed 
toward the common glucuronic acid constituent.  These observations and 
the  fact  that  the  isomeric galacturonic  acid  antiserum  fails  to  protect 
against infection with Type II pneumococci, afford evidence that the hex- 48  IMMUNITY INDUCED BY  ARTIFICIAL ANTIGENS.  II 
uronic acid constituent of the Type II specific polysaccharide is probably 
glucuronic acid. 
There remains still one perplexing fact to be considered.  Although cello- 
biuronic,  gentiobiuronic,  and  glucuronic  acid  antisera  all  confer passive 
immunity  on  mice  against  infection  with  Type  II  organisms,  specific 
agglutinins and precipitins are not  demonstrable in any of these antisera. 
Although the reactions of agglutination and precipitation are not  demon- 
strable in vitro it is possible to show that  the immune bodies combine with 
the organisms, for absorption of the sera  1 with encapsulated Type II pneu- 
mococci removes the protective antibodies,  whereas  absorption  with  the 
R  or unencapsulated strain does not.  On the basis of specific protective 
tests it is evident that it has been possible to produce in rabbits antibacterial 
sera  with  artificially  compounded  antigens  containing  saccharides  of 
synthetic rather than of bacterial origin. 
SUMMARY 
1.  Azoproteins containing  structurally isomeric  aldobionic  acids  evoke 
in  rabbits  antibodies  which  are  both  serologically  and  immunologically 
specific. 
2.  Antigens containing the azobenzyl glycosides of the synthetic gentio- 
biuronic  and  glucuronic  acids  evoke  in  rabbits  antibodies  which  confer 
passive immunity on mice against infection with multiple lethal doses of 
virulent Type II pneumococci. 
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